Cite
HARVARD Citation
Boumediene, A. et al. (2018). NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome. Journal of autoimmunity. pp. 91-102. [Online].